Add BrightSurf on Google Email

Semaglutide significantly improves blood sugar control and weight loss in adults with type 2 diabetes for up to 3 years in real-world study

A real-world study of over 23,000 adults with type 2 diabetes found that semaglutide significantly improved blood sugar control and weight loss for up to 3 years. The study showed that patients who had never taken a GLP-1 RA or those with higher adherence achieved more pronounced reductions in blood sugar levels and weight loss.

New study provides evidence for more effective brain-based treatment of chronic back pain

A new study published in JAMA Network Open suggests that reattribution of pain to mind or brain processes can lead to significant reductions in chronic back pain intensity. Participants who received pain reprocessing therapy reported being pain-free or nearly so after treatment, compared to those receiving placebo controls.

Brief dialysis may be best for some kidney patients

A study by UC San Francisco researchers found that patients with acute kidney injury on outpatient dialysis may not need lifelong treatment if they have the potential to recover. The study tracked data from over 1,700 patients and showed that approximately three-quarters of those who recovered kidney function discontinued dialysis with...

SourceUniversity of California - San Francisco·JournalJournal of the American Society of Nephrology·DateSep 28, 2023

"Radar" detects active cellular destroyers

A team of scientists has developed a method to detect active Cullin-RING ligases (CRLs), which are responsible for destroying unwanted proteins in cells. The new technology, called a molecular radar, reveals which CRLs are deployed to address cellular stresses and perform the actions of some anti-cancer drugs.

SourceMax-Planck-Gesellschaft·JournalNature Chemical Biology·TypeExperimental study·DateSep 26, 2023

Insilico Medicine and University of Cambridge present new approach to discover targets for Alzheimer’s and other diseases with protein phase separation

Researchers identified potential therapeutic targets for Alzheimer's disease and other conditions using a new approach combining AI-driven target identification with protein phase separation analysis. The study provides insights into the role of protein phase separation in human disease and its potential as a therapeutic target.

SourceInSilico Medicine·JournalProceedings of the National Academy of Sciences·DateSep 25, 2023

Kinase-targeted therapy in subsets of colorectal cancer

Researchers explore kinase inhibitors as targeted therapies for specific CRC subsets, offering hope for improved treatment options. Key findings suggest that uncovering essential kinases for tumor growth can lead to more effective treatment strategies in metastatic or later-stage CRC patients.

SourceImpact Journals LLC·JournalOncoscience·TypeCommentary/editorial·DateSep 22, 2023

Three new articles in the Special Issue “Single-Cell and Spatially Resolved Omics - I” of Journal of Pharmaceutical Analysis Articles describe how single-cell and spatially resolved omics can identify novel therapeutic targets

Researchers have identified novel therapeutic targets using single-cell and spatially resolved omics, including cannabidiol for colorectal tumors, Cux1 as a potential target for dry skin diseases, and microglia communication for Alzheimer's disease. These studies offer hope for future treatments.

SourceCactus Communications·JournalJournal of Pharmaceutical Analysis·TypeExperimental study·DateSep 18, 2023

UCI researchers announce publication of an open-label clinical trial suggesting that N-acetylglucosamine restores neurological function in Multiple Sclerosis patients

A study published by UCI researchers found that N-acetylglucosamine reduced multiple inflammation and neurodegeneration markers in patients with Multiple Sclerosis. The dietary supplement also improved neurological function in 30% of patients, suggesting a potential new treatment for the condition.

SourceUniversity of California - Irvine·JournalJournal of Neuroinflammation·TypeRandomized controlled/clinical trial·DateSep 14, 2023

Immune system plays vital role in longer multiple myeloma remission

Researchers found that patients' immune systems play a vital role in determining the duration of remission from multiple myeloma. Sustained minimal residual disease (MRD) negativity is associated with prolonged survival, with patients achieving MRD negativity for at least two years remaining free from multiple myeloma 10 years later.

SourceUniversity of Miami Miller School of Medicine·JournalNature Communications·DateSep 6, 2023

Adrenocortical carcinoma: No mitotane for low risk of recurrence

A new clinical study found that adjuvant treatment with Mitotane is not necessary for patients with low risk of recurrence if they have a complete R0 resection, low tumour stage and Ki-67 levels below 10%. This approach has shown no significant improvement in relapse rate but is associated with side effects.

SourceUniversity of Würzburg·JournalThe Lancet Diabetes & Endocrinology·TypeRandomized controlled/clinical trial·DateAug 25, 2023

Metabolite in urine predicts diabetic kidney failure 5-10 years early; oral therapeutic drug shows promise in mice

Researchers found that urine levels of adenine are predictive and causative biomarkers of looming progressive kidney failure in patients with diabetes. An oral therapeutic drug showed promise in mice by reducing kidney adenine levels and protecting against diabetic kidney disease.

SourceUniversity of Texas Health Science Center at San Antonio·JournalJournal of Clinical Investigation·TypeExperimental study·DateAug 24, 2023

Moffitt researchers use mathematical modeling and dynamic biomarkers to characterize metastatic disease during adaptive therapy

Moffitt researchers used mathematical modeling and dynamic biomarkers to identify characteristics of metastatic disease associated with better treatment outcomes. They found that larger metastases had longer treatment cycles, while those with faster cell turnover rates responded quickly to treatment.

SourceH. Lee Moffitt Cancer Center & Research Institute·JournalCancer Research·TypeComputational simulation/modeling·DateAug 15, 2023

New research shines light on how COVID-19 vaccination reduces severity and mortality after breakthrough infections

A large study found that fully vaccinated individuals have lower concentrations of inflammatory markers than unvaccinated participants after symptomatic COVID-19 infection. This suggests that vaccination significantly reduces morbidity and mortality by reducing elevated levels of cytokines and chemokines.

SourceUniversity of Colorado Anschutz Medical Campus·JournalThe Lancet Microbe·DateAug 7, 2023

Hydrogen sulfide shows promise as healthy ageing therapeutic when specifically targeted within cells

Targeting tiny amounts of hydrogen sulfide to specific areas of cells in adult worms improved health and activity as they aged, according to a University of Exeter study. The research found that H2S improved the integrity of mitochondria, kept muscles active, and extended lifespan.

SourceUniversity of Exeter·JournalProceedings of the National Academy of Sciences·TypeExperimental study·DateJul 31, 2023

Human senescent fibroblasts cause lung fibrosis in mice

Researchers found that human senescent fibroblasts trigger progressive lung fibrosis in immunodeficient mice by inducing paracrine senescence and pro-fibrotic activities. The study also suggests that senolytic compounds like navitoclax can ameliorate lung fibrosis induced by senescent human fibroblasts.

SourceImpact Journals LLC·JournalAging-US·TypeExperimental study·DateJul 31, 2023

Journal of Pharmaceutical Analysis studies make advances in spatiotemporal pharmacometabolomics, plasma proteome profiling, and hepatocellular carcinoma therapeutics

Researchers developed new methods for detecting drug-induced hepatotoxicity using 3D cell cultures and mass spectrometry imaging, identifying biomarkers and effective interventions. A zeolite-based protein corona method was also used to characterize plasma proteins, enabling the identification of low-abundance proteins and their potent...

SourceCactus Communications·JournalJournal of Pharmaceutical Analysis·TypeExperimental study·DateJul 26, 2023

Study finds new, unexpected mechanism of cancer cell spread

A new study reveals that the cellular chaperone protein GRP78 migrates to the nucleus under stress and alters gene activities, allowing cancer cells to become more mobile and invasive. This discovery offers potential new approaches for cancer treatment, including down-regulating GRP78 activity or preventing it from binding to ID2.

SourceKeck School of Medicine of USC·JournalProceedings of the National Academy of Sciences·TypeExperimental study·DateJul 24, 2023

Mayo Clinic researchers pave the way for individualized obesity therapy, tailoring interventions to a person’s needs

Researchers developed a tailored approach to weight loss and cardiometabolic risk factors, showing significant improvement in targeted areas like abnormal fullness and emotional eating. The study suggests the need for an actionable, phenotype-based classification of patients in obesity treatment, moving beyond reliance on scales or bod...

SourceMayo Clinic·JournalEClinicalMedicine·DateJul 21, 2023